Pfizer Inc.
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionUllmann Financial Group, Inc.
Latest Disclosed Ownership9,648 shares
Latest Disclosed Value $ 270,922
Ullmann Financial Group, Inc. reports 9.59% increase in ownership of PFE / Pfizer Inc.

On April 13, 2026 - Ullmann Financial Group, Inc. filed a 13F-HR form disclosing ownership of 9,648 shares of Pfizer Inc. (US:PFE) valued at $270,916 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 8,804 shares of Pfizer Inc.. This represents a change in shares of 9.59% during the quarter. The current value of the position is $244,480 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F PFIZER COM 717081103 9,648 844 9.59 271 24.42 0.0281
2026-02-12 2025-12-31 13F PFIZER COM 717081103 8,804 4 0.05 217 -3.12 0.0226
2025-10-17 2025-09-30 13F PFIZER COM 717081103 8,800 8,800 224 0.0245
2023-04-11 2023-03-31 13F PFIZER COM 717081103 0 -5,867 -100.00 0 -100.00
2023-01-19 2022-12-31 13F PFIZER COM 717081103 5,867 -219 -3.60 301 12.78 0.0739
2022-10-12 2022-09-30 13F PFIZER COM 717081103 6,086 -101 -1.63 266 -17.90 0.0733
2022-07-13 2022-06-30 13F PFIZER COM 717081103 6,187 428 7.43 324 8.72 0.0878
2022-04-14 2022-03-31 13F PFIZER COM 717081103 5,759 335 6.18 298 -6.87 0.0762
2022-01-26 2021-12-31 13F PFIZER COM 717081103 5,424 -206 -3.66 320 32.23 0.0855
2021-10-19 2021-09-30 13F PFIZER INC COM COM 717081103 5,630 5,630 242 0.0956
2017-11-14 2017-09-30 13F Pfizer COM 717081103 0 -234 -100.00 0 -100.00
2017-07-24 2017-06-30 13F Pfizer COM 717081103 234 -508 -68.46 7 -72.00 0.0050
2017-05-26 2017-03-31 13F Pfizer COM 717081103 742 742 25 0.0207
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.